GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Head-Lice Preventative Shampoo Coming to US Market

20 Jan 2014 07:00

RNS Number : 0029Y
TyraTech, Inc.
20 January 2014
 



 

20 January 2014

TyraTech, Inc.

("TyraTech" or the "Company")

 

Vamousse head lice preventative shampoo coming to market in the USA

 

TyraTech, Inc. (AIM: TYR and TYRU) a life sciences company focusing on nature-derived insect and parasite control products, is pleased to announce its pioneering, over-the-counter head lice preventative shampoo product, Vamousse™, is now listed with the USA Food and Drug Administration ("FDA") and will be available for sale in the USA from the end of Q1 2014. The Vamousse Preventative Shampoo is a new product in the Vamousse range of head lice products and complements the Vamousse Treatment.

 

The Vamousse™ preventative shampoo product is targeting a new market, the prevention rather than the treatment of head lice infestation. The product provides a unique solution to help prevent head lice infestation. The shampoo can be used on a regular basis to prevent head lice infestation in children in at-risk situations (sleep-overs, camps, sports, events with friends, etc.) as well as to protect the whole family when an infestation occurs in one of its members. TyraTech believes that this product has the potential to give it access to a new market segment for prevention and for routine use of the product whereas existing head lice treatments are only used on an emergency basis and only for individuals that are already infested.

 

In addition, the new Vamousse™ preventative shampoo product will enable TyraTech to further expand its market penetration by offering a larger range of products for both head lice treatment and prevention. TytraTech believes that the Vamousse Preventative Shampoo will be distributed initially on-line and in brick-and-mortar distributors in the USA.

 

Bruno Jactel, Chief Executive Officer, said: "We have been working diligently to accelerate the development of this breakthrough preventative head lice shampoo targeting a new and potentially significant market. We are delighted to announce that we are now FDA listed and ready to launch in the US market. This product will be available soon in traditional retail and internet-based distributors. We feel confident that TyraTech's unique and complete product offering will help us to establish a significant market presence. TyraTech believes it is well positioned to meet market expectations for 2014 revenues."

 

Further information on Vamousse is available on the Company's website at: http://www.tyratech.com/content/company-products/head-lice.asp

 

For further information please contact:

 

TyraTech Inc.Alan Reade, Non-Executive ChairmanBruno Jactel, Chief Executive Officer

Tel: +44 7841 978709 Tel: +1 919 415 4340

 

SPARK Advisory Partners Limited, Nominated Adviser

Matt Davis / Mark Brady

Tel: +44 20 3368 3551

 

Allenby Capital Limited , Joint Broker

Chris Crawford

 

Whitman Howard Limited, Joint Broker

Ranald Mc-Gregor Smith / Niall Devins

 

Walbrook, Financial PR and IRBob Huxford /Guy McDougall (Public Relations)Paul Cornelius (Investor Relations)

 

Tel: +44 20 3328 5656

 

 

Tel: +44 20 7087 4555

 

Tel: +44 20 7933 8792 Tel: +44 20 7933 8794

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSTLIIALIS
Date   Source Headline
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20184:35 pmRNSPrice Monitoring Extension
28th Sep 20182:06 pmRNSSecond Price Monitoring Extn
28th Sep 20182:00 pmRNSPrice Monitoring Extension
28th Sep 201811:05 amRNSSecond Price Monitoring Extn
28th Sep 201811:00 amRNSPrice Monitoring Extension
28th Sep 20189:05 amRNSSecond Price Monitoring Extn
28th Sep 20189:00 amRNSPrice Monitoring Extension
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.